128 related articles for article (PubMed ID: 8584278)
21. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
[TBL] [Abstract][Full Text] [Related]
22. In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium.
Staal RG; Hogan KA; Liang CL; German DC; Sonsalla PK
J Pharmacol Exp Ther; 2000 May; 293(2):329-35. PubMed ID: 10772999
[TBL] [Abstract][Full Text] [Related]
23. Differential time courses of exogenous 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine and its metabolite MPP+ in the rat striatum and nucleus accumbens measured using in vivo voltammetry.
Nakazato T; Akiyama A
Brain Res; 1998 Nov; 812(1-2):150-6. PubMed ID: 9813295
[TBL] [Abstract][Full Text] [Related]
24. Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents.
Lin CJ; Tai Y; Huang MT; Tsai YF; Hsu HJ; Tzen KY; Liou HH
J Neurochem; 2010 Aug; 114(3):717-27. PubMed ID: 20477935
[TBL] [Abstract][Full Text] [Related]
25. (+)MK-801 does not prevent MPTP-induced loss of nigral neurons in mice.
Chan P; Di Monte DA; Langston JW; Janson AM
J Pharmacol Exp Ther; 1997 Jan; 280(1):439-46. PubMed ID: 8996226
[TBL] [Abstract][Full Text] [Related]
26. Comparison of key steps in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in rodents.
Sundström E; Samuelsson EB
Pharmacol Toxicol; 1997 Nov; 81(5):226-31. PubMed ID: 9396088
[TBL] [Abstract][Full Text] [Related]
27. 2'-NH(2)-MPTP [1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine] depletes serotonin and norepinephrine in rats: a comparison with 2'-CH(3)-MPTP [1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine].
Unger EL; Mazzola-Pomietto P; Murphy DL; Andrews AM
J Pharmacol Exp Ther; 2002 Nov; 303(2):527-33. PubMed ID: 12388632
[TBL] [Abstract][Full Text] [Related]
28. Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice.
Dluzen DE
Brain Res; 1996 Apr; 715(1-2):113-8. PubMed ID: 8739629
[TBL] [Abstract][Full Text] [Related]
29. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
[TBL] [Abstract][Full Text] [Related]
30. Metabolism of [14C]MPTP in mouse and monkey implicates MPP+, and not bound metabolites, as the operative neurotoxin.
Yang SC; Johannessen JN; Markey SP
Chem Res Toxicol; 1988; 1(4):228-33. PubMed ID: 2979736
[TBL] [Abstract][Full Text] [Related]
31. Differences in the disposition and toxicity of 1-methyl-4-phenylpyridinium in cultured rat and mouse astrocytes.
Tsai MJ; Lee EH
Glia; 1994 Dec; 12(4):329-35. PubMed ID: 7890335
[TBL] [Abstract][Full Text] [Related]
32. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
[TBL] [Abstract][Full Text] [Related]
33. Eldepryl prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigral neuronal apoptosis in mice.
Guo M; Chen S; Liu Z; Chen H
Chin Med J (Engl); 2001 Mar; 114(3):240-3. PubMed ID: 11780305
[TBL] [Abstract][Full Text] [Related]
34. Reduction of zinc-positive terminal fields in striatum of mouse after 1-methyl-4-phenylpyridinium neurotoxicity.
Rojas P; Franco-Pérez JE; Rojas C; Rojas-Castañeda J; Ebadi M; Fernández-Valverde F; Serrano-García N
Neurotoxicology; 2005 Dec; 26(6):959-68. PubMed ID: 15950287
[TBL] [Abstract][Full Text] [Related]
35. No apparent difference in the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on the sympathetic system in NMRI and C57 BL/6 mice.
Luthman J; Sundström E
Toxicol Lett; 1990 Nov; 54(1):83-92. PubMed ID: 2123046
[TBL] [Abstract][Full Text] [Related]
36. Melatonin protects against MPTP/MPP+ -induced mitochondrial DNA oxidative damage in vivo and in vitro.
Chen LJ; Gao YQ; Li XJ; Shen DH; Sun FY
J Pineal Res; 2005 Aug; 39(1):34-42. PubMed ID: 15978055
[TBL] [Abstract][Full Text] [Related]
37. MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice.
Viaggi C; Vaglini F; Pardini C; Caramelli A; Corsini GU
Neuropharmacology; 2009 Jun; 56(8):1075-81. PubMed ID: 19298832
[TBL] [Abstract][Full Text] [Related]
38. Effect of MPTP on brain mitochondrial H2O2 and ATP production and on dopamine and DOPAC in the striatum.
Fabre E; Monserrat J; Herrero A; Barja G; Leret ML
J Physiol Biochem; 1999 Dec; 55(4):325-31. PubMed ID: 10731084
[TBL] [Abstract][Full Text] [Related]
39. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
Leng A; Mura A; Hengerer B; Feldon J; Ferger B
Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025
[TBL] [Abstract][Full Text] [Related]
40. A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.
Kawasaki T; Ago Y; Kitao T; Nashida T; Takagi A; Takuma K; Matsuda T
Neuropharmacology; 2008 Oct; 55(5):654-60. PubMed ID: 18573265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]